A
Adaptimmune - ADR (ADAP)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adaptimmune - ADR (ADAP)
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
- USD1.06
- USD1.09
- USD1.03
- USD2.05
- -29.30%
- 48M
- 1.16M
- 1.31M
- 250M
- 0.42
- -21.00%
Stock News
2 hours ago
Trump VP contender Kristi Noem stands by killing her dog Cricket amid bipartisan ridicule
CNBC
4 hours ago
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
Yahoo
4 hours ago
Does the TikTok Ban Make Alphabet Stock a Buy?
Yahoo
4 hours ago
Could Salesforce Stock Help You Become a Millionaire?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
